Conference Coverage

Tapering TNFi’s safe and much cheaper in RA

Publish date: December 1, 2014

 

AT THE ACR ANNUAL MEETING

References

Dr. van Herwaarden’s study was internally funded. Dr. Yoshida’s study was supported by a grant to Kameda Medical Center, Kamogawa City, Japan. Both physicians reported having no relevant disclosures.

Pages

Recommended Reading

Children born to mothers with RA more likely to be born early
MDedge Family Medicine
VIDEO: RA linked to increased mortality in Nurses’ Health Study
MDedge Family Medicine
Novel program improves RA care, cuts costs
MDedge Family Medicine
Treat-to-target approach cuts mortality risk in RA patients
MDedge Family Medicine
RA draft guidelines: Treat to target
MDedge Family Medicine
RA increases mortality, particularly for respiratory causes, in women
MDedge Family Medicine
VIDEO: Herpes zoster vaccination: Is it safe for rheumatology patients over age 30 on biologics?
MDedge Family Medicine
VIDEO: Collaborative clinic aims at heart of CVD prevention in rheumatic diseases
MDedge Family Medicine
VIDEO: DAGR may prove to be safer alternative to glucocorticoids
MDedge Family Medicine
Nonsteroidal ‘DAGR’ looks sharp against RA
MDedge Family Medicine